+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Latex Agglutination Test Kits Market Size, Share & Trends Analysis Report by Product Type (ELISA, Indirect Fluorescent), Test Type (Antibody Detection), Sample Type (Blood), End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 5936562
Description Jump to:
The global latex agglutination test kits market is expected to reach USD 934.77 million by 2030 and is projected to grow at a CAGR of 5.65% from 2024 to 2030. The surge in infectious and chronic diseases such as rheumatoid arthritis, increasing demand for point-of-care testing, coupled with rising awareness are the key factors boosting the market. Furthermore, increasing investment in R&D activities as well as the growing initiatives by the key players are anticipated to offer lucrative opportunities for the market over the forecast period.

Latex agglutination test kits market is driven by the rising prevalence of infectious and autoimmune diseases. These tests are readily available and play a crucial role in the diagnosis of diseases such as tuberculosis, hepatitis, meningitis, Haemophilus influenza, typhoid, and pneumonia. For instance, according to the WHO, in 2021, an estimated 10.6 million individuals were affected with tuberculosis globally. Additionally, autoimmune conditions such as lupus and rheumatoid arthritis are on the rise. The availability of specialized kits like SLE Latex agglutination and Waaler Rose latex test kits is contributing to this growth. These tests offer rapid diagnostic capabilities, addressing the urgent healthcare needs associated with infectious and autoimmune diseases. The market expansion is further driven by the demand for accurate and swift diagnostic methods in the face of these healthcare challenges.

These kits offer several advantages such as, eliminates the need for waiting to interpret test results and helps in efficient patient care. In addition, it significantly reduces the cost of diagnosis and contributes to timely treatment decisions, especially in regions with limited laboratory infrastructure and resource constraints. The growing trend of decentralized testing has played a crucial role in driving the global adoption of these products. Thus, the numerous benefits provided by these tests are key factors contributing to their increasing adoption across the globe.

However, the emergence of reliable and novel alternate diagnostic tests, especially in developed economies such as U.S. and UK are anticipated to hamper the market over the forecast period. In addition, the limitations such as cross reactivity & standardization of the kits and technological advancements in point-of-care device for the diagnosis of infectious in various settings including hospitals and clinics many impede the market to certain extent during the study period.

Latex Agglutination Test Kits Market Report Highlights

  • ELISA segment dominated the latex agglutination test kits market in 2023 owing to the high prevalence of the disease and increasing R&D activities and growing investments for the diagnosis of diseases
  • By test type, antibody detection segment held the largest segment share of the latex agglutination test kits market 2023, attributable to their high specificity and sensitivity
  • Blood segment held the largest segment share of the latex agglutination test kits market in 2023, attributable to their reliability and accuracy in disease diagnosis
  • By end-use, the hospital pharmacies segment held the largest share of latex agglutination test kits market in 2023. This growth can be attributed to numerous factors, including easy accessibility of these products through hospital pharmacies
  • North America has established a strong regional position with a 42.97% share in 2023, owing to the increasing funding for development of novel diagnostics, high disposable income, technological advancements, and presence of key operating players in the region

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. COMMODITY FLOW ANALYSIS
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Rising prevalence of infectious and autoimmune diseases
3.4.2. Increasing demand for point-of-care testing (POCT)
3.4.3. Growing R&D activities
3.5. Market Restraint Analysis
3.5.1. Emergence of reliable and novel diagnostics
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Product Type Business Analysis
4.1. Latex Agglutination Test Kits market: Product Type Movement Analysis
4.2. ELISA
4.2.1. ELISA Market, 2018-2030 (USD Million)
4.3. Indirect Fluorescent
4.3.1. Indirect Fluorescent Market, 2018-2030 (USD Million)
4.4. Hemagglutination Inhibition
4.4.1. Hemagglutination Inhibition Market, 2018-2030 (USD Million)
4.5. Serum Neutralization
4.5.1. Serum Neutralization Inhibition Market, 2018-2030 (USD Million)
Chapter 5. Test Type Business Analysis
5.1. Latex Agglutination Test Kits Market: Test Type Movement Analysis
5.2. Antibody Detection
5.2.1. Antibody Detection Market, 2018-2030 (USD Million)
5.3. Antigen Testing
5.3.1. Antigen Testing Market, 2018-2030 (USD Million)
Chapter 6. Sample Type Business Analysis
6.1. Latex Agglutination Test Kits Market: Sample Type Movement Analysis
6.2. Blood
6.2.1. Blood Market, 2018-2030 (USD Million)
6.3. Urine
6.3.1. Urine Market, 2018-2030 (USD Million)
6.4. Cerebrospinal Fluid
6.4.1. Cerebrospinal Fluid Market, 2018-2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018-2030 (USD Million)
Chapter 7. End-use Business Analysis
7.1. Latex Agglutination Test Kits Market: Distribution Channel Movement Analysis
7.2. Hospital Pharmacies
7.2.1. Hospital Pharmacies Market, 2018-2030 (USD Million)
7.3. Retail Pharmacies
7.3.1. Retail Pharmacies Market, 2018-2030 (USD Million)
7.4. Online Pharmacies
7.4.1. Online Pharmacies Market, 2018-2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Latex Agglutination Test Kits Market Share By Region, 2023 & 2030
8.2. North America
8.2.1. North America Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Target Disease Prevalence
8.2.2.3. Competitive Scenario
8.2.2.4. Regulatory Framework
8.2.2.5. Reimbursement Scenario
8.2.2.6. U.S. Latex Agglutination Test Kits market, 2018-2030 (USD MILLION)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. Reimbursement Scenario
8.2.3.6. Canada Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.3. Europe
8.3.1. Europe Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.3.2. Germany
8.3.2.1. Key Country Dynamics
8.3.2.2. Target Disease Prevalence
8.3.2.3. Competitive Scenario
8.3.2.4. Regulatory Framework
8.3.2.5. Reimbursement Scenario
8.3.2.6. Germany Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. Reimbursement Scenario
8.3.3.6. UK Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Reimbursement Scenario
8.3.4.6. France Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. Reimbursement Scenario
8.3.5.6. Italy Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Reimbursement Scenario
8.3.6.6. Spain Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Reimbursement Scenario
8.3.7.6. Denmark Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Reimbursement Scenario
8.3.8.6. Sweden Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Reimbursement Scenario
8.3.9.6. Norway Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.4. Asia-Pacific
8.4.1. Asia-Pacific Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Competitive Scenario
8.4.2.4. Regulatory Framework
8.4.2.5. Reimbursement Scenario
8.4.2.6. Japan Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Reimbursement Scenario
8.4.3.6. China Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. Reimbursement Scenario
8.4.4.6. India Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. Reimbursement Scenario
8.4.5.6. South Korea Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Reimbursement Scenario
8.4.6.6. Australia Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. Reimbursement Scenario
8.4.7.6. Thailand Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Competitive Scenario
8.5.2.4. Regulatory Framework
8.5.2.5. Reimbursement Scenario
8.5.2.6. Brazil Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Reimbursement Scenario
8.5.3.6. Mexico Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Reimbursement Scenario
8.5.4.6. Argentina Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.6. MEA
8.6.1. MEA Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Competitive Scenario
8.6.2.4. Regulatory Framework
8.6.2.5. Reimbursement Scenario
8.6.2.6. South Africa Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. Reimbursement Scenario
8.6.3.6. Saudi Arabia Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. Reimbursement Scenario
8.6.4.6. UAE Latex Agglutination Test Kits market, 2018-2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. Reimbursement Scenario
8.6.5.6. Kuwait Latex Agglutination Test Kits market, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant’s overview
9.2. Financial performance
9.3. Participant categorization
9.3.1. Market Leaders
9.3.2. Latex Agglutination Test Kits market Share Analysis, 2023
9.3.3. Company Profiles
9.3.3.1. Eurofins Abraxis
9.3.3.1.1. Company Overview
9.3.3.1.2. Financial Performance
9.3.3.1.3. Product Benchmarking
9.3.3.1.4. Strategic Initiatives
9.3.3.2. Thermo Fisher Scientific Inc.
9.3.3.2.1. Company Overview
9.3.3.2.2. Financial Performance
9.3.3.2.3. Product Benchmarking
9.3.3.2.4. Strategic Initiatives
9.3.3.3. bioMérieuxSA
9.3.3.3.1. Company Overview
9.3.3.3.2. Financial Performance
9.3.3.3.3. Product Benchmarking
9.3.3.3.4. Strategic Initiatives
9.3.3.4. Bioloegend Inc.
9.3.3.4.1. Company Overview
9.3.3.4.2. Financial Performance
9.3.3.4.3. Product Benchmarking
9.3.3.4.4. Strategic Initiatives
9.3.3.5. HiMedia Laboratories Microbiology International
9.3.3.5.1. Company Overview
9.3.3.5.2. Financial Performance
9.3.3.5.3. Product Benchmarking
9.3.3.5.4. Strategic Initiatives
9.3.3.6. Biotium
9.3.3.6.1. Company Overview
9.3.3.6.2. Financial Performance
9.3.3.6.3. Product Benchmarking
9.3.3.6.4. Strategic Initiatives
9.3.3.7. Creative Diagnostics
9.3.3.7.1. Company Overview
9.3.3.7.2. Financial Performance
9.3.3.7.3. Product Benchmarking
9.3.3.7.4. Strategic Initiatives
9.3.3.8. Bio-Rad Laboratories, Inc.
9.3.3.8.1. Company Overview
9.3.3.8.2. Financial Performance
9.3.3.8.3. Product Benchmarking
9.3.3.8.4. Strategic Initiatives
9.3.3.9. Cardinal Health
9.3.3.9.1. Company Overview
9.3.3.9.2. Financial Performance
9.3.3.9.3. Product Benchmarking
9.3.3.9.4. Strategic Initiatives
9.3.3.10. Atlas Medical GmbH
9.3.3.10.1. Company Overview
9.3.3.10.2. Financial Performance
9.3.3.10.3. Product Benchmarking
9.3.3.10.4. Strategic Initiatives
9.3.4. Strategy Mapping
9.3.4.1. Expansion
9.3.4.2. Acquisition
9.3.4.3. Collaborations
9.3.4.4. Disease Type/Drug Class Launch
9.3.4.5. Partnerships
9.3.4.6. Others
List of Tables
Table 1 List of Abbreviations
Table 2 Global Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 3 Global Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 4 Global Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 5 Global Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 6 Global Latex Agglutination Test Kits Market, by Region, 2018-2030 (USD Million)
Table 7 North America Latex Agglutination Test Kits Market, by Country, 2018-2030 (USD Million)
Table 8 North America Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 9 North America Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 10 North America Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 11 North America Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 12 U.S. Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 13 U.S. Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 14 U.S. Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 15 U.S. Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 16 Canada Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 17 Canada Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 18 Canada Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 19 Canada Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 20 Europe Latex Agglutination Test Kits Market, by Country, 2018-2030 (USD Million)
Table 21 Europe Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 22 Europe Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 23 Europe Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 24 Europe Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 25 Germany Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 26 Germany Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 27 Germany Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 28 Germany Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 29 UK Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 30 UK Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 31 UK Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 32 UK Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 33 France Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 34 France Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 35 France Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 36 France Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 37 Italy Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 38 Italy Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 39 Italy Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 40 Italy Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 41 Spain Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 42 Spain Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 43 Spain Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 44 Spain Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 45 Denmark Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 46 Denmark Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 47 Denmark Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 48 Denmark Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 49 Sweden Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 50 Sweden Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 51 Sweden Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 52 Sweden Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 53 Norway Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 54 Norway Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 55 Norway Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 56 Norway Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 57 Asia-Pacific Latex Agglutination Test Kits Market, by Country, 2018-2030 (USD Million)
Table 58 Asia-Pacific Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 59 Asia-Pacific Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 60 Asia-Pacific Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 61 Asia-Pacific Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 62 China Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 63 China Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 64 China Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 65 China Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 66 Japan Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 67 Japan Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 68 Japan Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 69 Japan Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 70 India Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 71 India Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 72 India Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 73 India Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 74 South Korea Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 75 South Korea Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 76 South Korea Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 77 South Korea Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 78 Australia Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 79 Australia Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 80 Australia Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 81 Australia Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 82 Thailand Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 83 Thailand Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 84 Thailand Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 85 Thailand Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 86 Latin America Latex Agglutination Test Kits Market, by Country, 2018-2030 (USD Million)
Table 87 Latin America Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 88 Latin America Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 89 Latin America Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 90 Latin America Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 91 Brazil Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 92 Brazil Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 93 Brazil Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 94 Brazil Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 95 Mexico Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 96 Mexico Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 97 Mexico Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 98 Mexico Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 99 Argentina Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 100 Argentina Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 101 Argentina Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 102 Argentina Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 103 Middle East & Africa Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 104 Middle East & Africa Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 105 Middle East & Africa Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 106 Middle East & Africa Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 107 Middle East & Africa Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 108 South Africa Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 109 South Africa Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 110 South Africa Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 111 South Africa Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 112 Saudi Arabia Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 113 Saudi Arabia Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 114 Saudi Arabia Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 115 Saudi Arabia Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 116 UAE Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 117 UAE Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 118 UAE Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 119 UAE Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
Table 120 Kuwait Latex Agglutination Test Kits Market, by Product Type, 2018-2030 (USD Million)
Table 121 Kuwait Latex Agglutination Test Kits Market, by Test Type, 2018-2030 (USD Million)
Table 122 Kuwait Latex Agglutination Test Kits Market, by Sample Type, 2018-2030 (USD Million)
Table 123 Kuwait Latex Agglutination Test Kits Market, by End-use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Latex Agglutination Test Kits Market Segmentation
Fig. 8 Market Snapshot, 2023
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Global Latex Agglutination Test Kits Market: Product Type Movement Analysis
Fig. 15 Global Latex Agglutination Test Kits Market, by ELISA, 2018-2030 (USD Million)
Fig. 16 Global Latex Agglutination Test Kits Market, by Indirect Fluorescent, 2018-2030 (USD Million)
Fig. 17 Global Latex Agglutination Test Kits Market, by Hemagglutination Inhibition, 2018-2030 (USD Million)
Fig. 18 Global Latex Agglutination Test Kits Market, by Serum Neutralization, 2018-2030 (USD Million)
Fig. 19 Global Latex Agglutination Test Kits Market: Test Type Movement Analysis
Fig. 20 Global Latex Agglutination Test Kits Market, by Antibody Detection, 2018-2030 (USD Million)
Fig. 21 Global Latex Agglutination Test Kits Market, by Antigen Testing, 2018-2030 (USD Million)
Fig. 22 Global Latex Agglutination Test Kits Market: Sample Type Movement Analysis
Fig. 23 Global Latex Agglutination Test Kits Market, by Blood 2018-2030 (USD Million)
Fig. 24 Global Latex Agglutination Test Kits Market, by Urine 2018-2030 (USD Million)
Fig. 25 Global Latex Agglutination Test Kits Market, by Cerebrospinal Fluid, 2018-2030 (USD Million)
Fig. 26 Global Latex Agglutination Test Kits Market, by Others, 2018-2030 (USD Million)
Fig. 27 Global Latex Agglutination Test Kits Market: End-use Movement Analysis
Fig. 28 Global Latex Agglutination Test Kits Market, by Hospital Pharmacies 2018-2030 (USD Million)
Fig. 29 Global Latex Agglutination Test Kits Market, by Retail Pharmacies 2018-2030 (USD Million)
Fig. 30 Global Latex Agglutination Test Kits Market, by Online Pharmacies, 2018-2030 (USD Million)
Fig. 31 Regional Marketplace: Key Takeaways
Fig. 32 Regional Outlook, 2023 & 2030
Fig. 33 Global Latex Agglutination Test Kits Market: Region Movement Analysis
Fig. 34 North America Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 35 U.S. Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 36 Canada Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 37 Europe Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 38 Germany Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 39 UK Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 40 France Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 41 Italy Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 42 Spain Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 43 Denmark Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 44 Sweden Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 45 Norway Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 46 Asia-Pacific Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 47 Japan Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 48 China Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 49 India Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 50 Australia Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 51 South Korea Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 52 Thailand Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 53 Latin America Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 54 Brazil Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 55 Mexico Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 56 Argentina Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 57 Middle East and Africa Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 58 South Africa Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 59 Saudi Arabia Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 60 UAE Latex Agglutination Test Kits Market, 2018-2030 (USD Million)
Fig. 61 Kuwait Latex Agglutination Test Kits Market, 2018-2030 (USD Million)

Companies Mentioned

  • Eurofins Abraxis
  • Thermo Fisher Scientific Inc.
  • bioMérieuxSA
  • Bioloegend Inc.
  • HiMedia Laboratories Microbiology International
  • Biotium
  • Creative Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health
  • Atlas Medical GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 639.02 Million
Forecasted Market Value ( USD ) by 2030 $ 934.77 Million
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Latex Agglutination Test Kits Market Report 2024 - Product Image

Global Latex Agglutination Test Kits Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Latex Agglutination Test Kits Market Report and Forecast 2024-2032 - Product Image

Latex Agglutination Test Kits Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Aflatoxin ELISA Test Kit Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Aflatoxin ELISA Test Kit Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 116 Pages
  • Global
From
Fumonisin ELISA Test Kit Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Fumonisin ELISA Test Kit Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 127 Pages
  • Global
From
Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report - Product Image

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report

  • Report
  • 163 Pages
  • Global
From

About the Latex Agglutination Test Kits Market

In the field of clinical diagnostics, latex agglutination test kits represent a rapid, convenient method for detecting the presence of specific antigens or antibodies in a sample, often related to infectious diseases, autoimmune disorders, and other medical conditions. These tests involve the use of latex beads coated with an antigen or antibody. When a sample containing the target substance is added, it binds to the coating, causing the beads to clump, or agglutinate. This agglutination can be visually observed, providing a qualitative or semi-quantitative result. Enzymes play a crucial role in enhancing these tests. They are sometimes conjugated to the antibodies or antigens on the latex beads, amplifying the agglutination reaction and thereby improving the sensitivity and specificity of the test. Such enzyme-enhanced assays are particularly useful where high accuracy is essential, such as in the diagnosis of certain diseases or the detection of minute antibody titers. Many companies operate in the market for latex agglutination test kits. Some well-renowned providers include Thermo Fisher Scientific, which offers a wide range of diagnostic solutions; Becton, Dickinson and Company, known for their medical devices and laboratory equipment; Merck KGaA, with a diversified portfolio including life sciences and healthcare; and Abbott, which develops medical devices and healthcare products. These companies, along with others such as Bio-Rad Laboratories and Cardinal Health, contribute to the availability and advancement of latex agglutination test technologies. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.